MENU
IFRX
AS OF
Dec 12 closing price
Price
$1.05
Change
+$0.03 (+2.94%)
Capitalization
71.13M
96 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IFRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

InflaRx (IFRX) Ownership - Who owns InflaRx?

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
71.13M
P/E Ratio
N/A
Total Cash
44.65M
Projected Growth
N/A
Total Debt
970.86K
Revenue
62.84K
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
0.66
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

IFRX
Capitalization
71.1M
P/E Ratio
N/A
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
44.6M
Total Cash/Share
0.66
Total Debt
971K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
62.8K
ROE
N/A
Book Value
45.4M
P/B Ratio
1.34
Cash Flow
N/A
Earnings
-0.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8.13M
Current Ratio
3.33
Current Revenue Per Employee
322.03
Dividends Per Share - Security
N/A
EBITDA
-39.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.60
Revenue To Assets
-55.37
Shares Held By Institutions
24.5M
Shares Outstanding - Current
67.7M
Total Liabilities
19.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-58.704
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IFRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IFRX showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IFRX
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Winzerlaer Strasse 2
Phone
+49 3641508180
Employees
66
Web
https://www.inflarx.de